肾脏透明细胞癌的病理诊断分析

目的：探讨肾脏透明细胞癌的病理诊断分析。方法整群选取2011年1月-2014年6月在该病理科进行肾脏透明细胞癌的病理诊断的163例患者作为研究对象,并对其病理资料进行回顾性分析。结果163例患者中,肾透明细胞癌玉级56例,占34.4%,肾透明细胞癌Ⅱ级43例,占26.4%,肾透明细胞芋级35例,占21.5%,肾透明细胞癌Ⅳ级29例,占17.7%。镜下可见肿瘤细胞体积较大,圆形或多边形,胞质丰富,透明状,间质富有毛细血管和血窦。结论病理诊断是在镜下观察组织结构和细胞病变特征而做出的疾病诊断,肾脏透明细胞癌是肾癌中最常见的恶性肿瘤,预后较好,及早进行病理诊断分析,可以大大的提高患者的生活质量。     

基底细胞癌的病理诊断分析及预后

目的：探讨基底细胞癌的病理诊断分析及预后。方法整群选取2010年10月—2014年5月在该病理科进行基底细胞癌的病理诊断的74例患者作为研究对象，并对其病理资料进行回顾性分析。结果74例基底细胞癌患者中，眶周部23例，占31.1%，峡部5例，占6.8%，额部9例，占12.2%，颧骨部7例，占9.4%，鼻翼部19例，占25.6%，上唇部6例，占8.1%，下颌部3例，占4.1%，背部2例，占2.7%。镜下可见瘤细胞团块状或巢状排列，细胞核大小不一，排列密集紊乱，胞浆少淡染，瘤细胞巢周围裂隙形成，间质慢性炎细胞浸润。结论基底细胞癌是皮肤科最常见的恶性肿瘤之一，及早进行病理诊断和治疗，预后较好，可以明显的提高患者的生命质量。     

胸腺肽结合床旁高流量CBP治疗脓毒症患者对其血清HBP和HO-1及血流动力学参数的影响

目的:探讨胸腺肽结合床旁高流量连续性血液净化(continuous blood purification, CBP)治疗脓毒症患者对其血清肝素结合蛋白(heparin binding protein, HBP)、血红素加氧酶-1(heme oxygenase-1,HO-1)及血流动力学参数的影响。方法:选取2021年7月—2022年3月于邢台市第三医院收治的88例脓毒症患者,依据随机数表法将患者分为O组及C组,44例C组患者给予床旁高流量CBP,在C组的基础上44例O组患者给予胸腺肽皮下注射,两组患者治疗2周后比较患者临床疗效、T细胞亚群、炎症因子、血清HBP、HO-1水平及血流动力学参数。结果:O组患者的临床总有效率为88.64%(39/44),明显高于C组的临床总有效率(70.45%,31/44),两组差异有统计学意义(P<0.05)。与C组患者治疗后比较,O组患者的CD3⁺及CD4⁺水平更高,CD8⁺水平更低,两组差异有统计学意义(P<0.05)。O组患者的TNF-α及IL-6水平低于C组,两组差异有统...     

石棒绣线菊对小鼠中枢神经系统的影响

石棒绣线菊水提物有镇静、镇痛、抗惊厥的中枢抑制作用。     

原生药材超细微粉制剂的药效学研究

采用超细微粉技术对原生药材进行微粉加工制成的外用和内服制剂与传统工艺比较,动物实验证明可提高后者的生物学效应,与传统粉碎工艺的制剂比较可明显提高药效学活性。     

系统性红斑狼疮患者血清骨桥蛋白检测及意义

摘要 目的：探讨血清骨桥蛋白（OPN）水平与系统性红斑狼疮（SLE）脏器受累及疾病活动的关系。方法：63例SLE患者依据疾病活动指数（SLEDAI）分为缓解组（0~8分）31例和活动组（≥9分）32例;依据肾功能、尿液分析及肾脏病理检查结果分为肾损害组（32例）和无肾损害组（31例）;依据肺间质有无纤维化将患者分为合并肺间质病变（ILD）组22例和未合并ILD组 41例;依据心电图、心脏彩色多普勒超声检查及心肌酶检查,分为心脏损害组25例和无心脏损害组38例;依据血常规检查结果分为合并血液系统损害组45例和无血液系统损害18例。采用酶联免疫吸附（ELISA）法检测上述SLE患者血清OPN水平,并与20例健康体检者（对照组）进行比较。结果：SLE患者血清OPN水平显著高于对照组（均P <0.05或P ＜ 0.01）。SLE合并肾损害、肺间质病变、心脏损害、血液系统损害组的血清OPN水平明显高于无相应脏器受累患者（均P ＜ 0.01）,SLE患者的血清OPN水平与SLEDAI评分呈显著正相关（r=0.982,P＜0.01）。结论： OPN在SLE发病机制中具有一定意义,并与疾病活动、脏器损害相关,血清OPN水平可以作为判断SLE疾病活动的实验室指标。     

血清骨桥蛋白水平与类风湿关节炎活动性的关系及在伴肺间质病变中的意义

Objective To investigate the association between serum level of osteopotin (OPN) and disease activity of rheumatoid arthritis (RA) patients, and explore the importance of OPN in the pathogenesis of interstitial lung disease (ILD) in RA. Methods Sixty-five RA patients and 20 healthy controls were pros-pectively enrolled. RA patients were divided into active group (n=43) and inactive group (n=22), and ILD groups (n=24) and non-ILD group (n=41). Enzyme-linked immunosorbent assay (ELISA) was used to detect the serum levels of OPN in patients with RA and healthy controls, and the relationship between OPN and other clinical and laboratory findings were analyzed. Results ① Serum OPN tended to be significantly higher in RA patients (median, 18.0 ng/ml) than in the healthy controls (median, 14.3 ng/ml), P<0.01; ②The serum level of OPN in RA patients showed a significant positive correlation with the course of disease, numbers of tender joints , ESR and CRP, but no positive relationship was found in number of swollen joints; ③ The serum level of OPN was significantly higher in RA-ILD patients (median, 20.0 ng/ml) than that in non-lLD (median, 17.0 ng/ml, P<0.05). And there was remarkable negative correlation between the concentration of serum OPN and the value of PaO2, but no association was found with pulmonary function %VC and %DLCO. ④ Compared with the non-ILD group, the ILD group had more active disease in terms of tender joint counts and swollen joint counts, ESR, CRP (P<0.01) and the serum titer of RF-IgM, (P<0.05). Conclusion OPN plays a role in the pathogenesis of RA and is related to the disease activity. It may serve as an active disease inflammatory marker of RA . OPN may be involved in the pathogenesis of RA related ILD and is associated with the severity of pulmonary damage.     

血清骨桥蛋白水平与类风湿关节炎活动性的关系及在伴肺间质病变中的意义

Objective To investigate the association between serum level of osteopotin (OPN) and disease activity of rheumatoid arthritis (RA) patients, and explore the importance of OPN in the pathogenesis of interstitial lung disease (ILD) in RA. Methods Sixty-five RA patients and 20 healthy controls were pros-pectively enrolled. RA patients were divided into active group (n=43) and inactive group (n=22), and ILD groups (n=24) and non-ILD group (n=41). Enzyme-linked immunosorbent assay (ELISA) was used to detect the serum levels of OPN in patients with RA and healthy controls, and the relationship between OPN and other clinical and laboratory findings were analyzed. Results ① Serum OPN tended to be significantly higher in RA patients (median, 18.0 ng/ml) than in the healthy controls (median, 14.3 ng/ml), P<0.01; ②The serum level of OPN in RA patients showed a significant positive correlation with the course of disease, numbers of tender joints , ESR and CRP, but no positive relationship was found in number of swollen joints; ③ The serum level of OPN was significantly higher in RA-ILD patients (median, 20.0 ng/ml) than that in non-lLD (median, 17.0 ng/ml, P<0.05). And there was remarkable negative correlation between the concentration of serum OPN and the value of PaO2, but no association was found with pulmonary function %VC and %DLCO. ④ Compared with the non-ILD group, the ILD group had more active disease in terms of tender joint counts and swollen joint counts, ESR, CRP (P<0.01) and the serum titer of RF-IgM, (P<0.05). Conclusion OPN plays a role in the pathogenesis of RA and is related to the disease activity. It may serve as an active disease inflammatory marker of RA . OPN may be involved in the pathogenesis of RA related ILD and is associated with the severity of pulmonary damage.     

不同肾脏替代治疗模式对脓毒症休克合并多脏器功能损害患者的疗效观察

目的：比较不同连续性肾脏替代治疗（continuous renal replacement therapy,CRRT）模式对脓毒症休克合并多脏器功能损害患者的临床疗效,为脓毒症休克合并多脏器功能损害的CRRT治疗模式选择提供参考依据。方法：选取我院2015年7月至2017年3月收治的92例脓毒症休克合并多脏器功能损害患者作为研究对象,按照随机数字表法分为连续性静-静脉血液滤过（CVVH）组和连续性静-静脉血液透析滤过（CVVHDF）组,每组各46例,分别给予CVVH及CVVHDF治疗。比较两组患者CRRT参数、治疗转归及治疗前后生化指标变化,分析两种治疗模式对患者预后的影响。 结果：两组患者比较,CVVH组矫正剂量（Kpc）、交付剂量（Kd）、实际溶质清除剂量（K）均低于CVVHDF组,差异均有统计学意义（P＜0.05）。两组患者治疗转归比较,差异均无统计学意义（P＞0.05）。两组患者治疗后尿素氮（BUN）、肌酐（Cr）、β2-微球蛋白（β2-MG）、急性生理与慢性健康（APACHEⅡ）评分均较治疗前下降;白细胞介素-6（IL-6）、排尿量均较治疗前升高;CVVH组患者β2-MG下降更为明显,差异均有统计学意义（P＜0.05）。两组患者治疗期间均未见不良反应发生。 结论：CVVH与CVVHDF模式治疗脓毒症休克合并多脏器功能损害的效果相仿,CVVHDF清除小分子溶质的能力较强,而CVVH清除中大分子的效果更为理想。